Sponsor

BC Cancer Foundation

Clinical research sponsor

Published trials9
Recruiting shown2
Roles1
SourceClinicalTrials.gov

Clinical trials

9 shown
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate CancerNCT06200974 · collaborator · 2024-02-01
RECRUITING
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityNCT04273061 · collaborator · 2020-06-17
RECRUITING
Prostate Cancer Biomarker Enrichment and Treatment SelectionNCT03385655 · collaborator · 2018-08-01
ACTIVE_NOT_RECRUITING
Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic SyndromeNCT03031821 · collaborator · 2018-07-12
TERMINATED
LDR vs. HDR Brachytherapy for Prostate CancerNCT03426748 · collaborator · 2018-02-15
ACTIVE_NOT_RECRUITING
The Oncopanel Pilot (TOP) StudyNCT02171286 · collaborator · 2014-10-01
COMPLETED
Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR BrachytherapyNCT01936883 · collaborator · 2014-01-01
ACTIVE_NOT_RECRUITING
Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to AsbestosNCT01719068 · collaborator · 2012-10-01
UNKNOWN
Pilot Study of Partial Breast Irradiation Utilizing Permanent Breast Seed Implant to Treat Breast CancerNCT01191164 · collaborator · 2011-09-01
UNKNOWN

Sponsor roles

collaborator9

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.